Clinical Trials Logo

Withdrawal Symptoms clinical trials

View clinical trials related to Withdrawal Symptoms.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03557294 Completed - Smoking Cessation Clinical Trials

Varenicline OTC Trial on Efficacy and Safety

VOTC
Start date: May 7, 2018
Phase: Phase 4
Study type: Interventional

The primary goal of the proposed research is to test whether varenicline (Chantix) is safe and effective as an over-the-counter (OTC) medication.

NCT ID: NCT02391571 Completed - Withdrawal Symptoms Clinical Trials

A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

Start date: February 2015
Phase: Phase 3
Study type: Interventional

This single-center study is a randomized, double-blind, active-controlled, multiple-dose, parallel group study to evaluate the potential withdrawal effects, safety and tolerability, and pharmacokinetic and pharmacodynamic effects of multiple doses of oral intact Oxycodone/Naltrexone capsules compared to oxycodone in methadone-maintained opioid-dependent subjects. The study will consist of a Screening Phase, an inpatient Treatment Phase (including a methadone stabilization period, a placebo administration period, a treatment administration period and a safety/washout period), and a Follow-up Phase.

NCT ID: NCT02044757 Completed - Withdrawal Symptoms Clinical Trials

The Potentially Addictive Properties of Soda: A Feasibility Study

Start date: June 2013
Phase: N/A
Study type: Interventional

The purpose of this study to investigate the addictive properties of soda and other sugar sweetened beverages (SBBs) in teenagers aged 13-18 years. It is hypothesized that participants who were regularly consuming sweetened and caffeinated beverages will experience symptoms typical of caffeine withdrawal, such as headache and fatigue, during the SSB withdrawal period.